MANGALAM DRUGS & ORGANICS LTD. - 532637 - Financial Results For The Quarter Ended 30.09.2023
Standalone and consolidated financial results for the period ended 30.09.202308-11-2023
08-11-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Update on board meeting
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Update on board meeting : To consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report there on for the quarter and half year ended September 30, 2023(Q2).01-11-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Consideration And Approval Of Un Audited Financial Results For The Quarter Ended 30.09.2023
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Un audited financial results for the quarter ended 30.09.202331-10-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 18, 2023 for Shree Kishoriju Trading and Investments Pvt Ltd18-10-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Reg. 74(5) of SEBI DP Regulations for the period ended 30.09.202313-10-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Report under Regulation 44 along with Scrutinizer''s Report03-10-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Restructuring
The Board of Directors in its meeting held on Saturday, September 30, 2023 has discussed and agreed to provide in principle approval to explore appropriate actions including Merger, Acquisition or other suitable arrangement options for restructuring businesses of Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited to align with long term objectives of the Company. Necessary intimation as required under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 shall be furnished on final approval of Board of Directors of the Company.01-10-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Acquisition
The Board of Directors in its meeting held on Saturday, September 30, 2023 has noted approval of transfer of 100 % shares in favor of the Company by Board of Directors of Mangalam Laboratories Private Limited in its Board Meeting held on September 30, 2023. Consequently, the Company has acquired 100 % stake in Mangalam Laboratories Private Limited thereby making it Wholly Owned Subsidiary of the Company.01-10-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window
CLOSURE OF TRADING WINDOW FROM 01ST OCTOBER 2023 TILL THE CONCLUSION OF 48 HOURS OF THE DECLARATION OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30 2023.30-09-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholder Meeting / Postal Ballot-Outcome of AGM
With reference to the captioned subject please find attached the proceedings of the 50th Annual General Meeting of the Company30-09-2023